Submitting INDs in eCTD Format: Master Compliant Drug and Biologic Submissions

Quantity Discounts
1 - 9999
1 - 9999
1 - 9999
IND submissions are on the rise — up 22 percent over the last three years — and the FDA is scrutinizing every submission.

Preparing and submitting an IND to CDER in eCTD format comes with many unique challenges, such as:

  • An IND submission that is provided over a longer period of time than other submissions requires a more comprehensive plan
  • Data from the IND stage may be used and presented in ways later on that weren't initially planned
  • How do you present preclinical/nonclinical study data
  • Knowing the point at which you should establish communication with the FDA in preparation for an eCTD submission

Don't risk a delay in the start of your IND review because it fails the FDA validation check on eCTD submissions ... find the actionable information you need to meet all the challenges and properly file these submissions.

Let eCTD expert Antoinette Azevedo show you the steps you need to prepare and submit an IND in eCTD format during this 90-minute Encore presentation. She'll explain the folder structure and content format for the document along with the navigation backbone standards. And she'll explain the FDA's perspective on INDs in eCTD format.
Antoinette will deliver the tips and tricks you need to master eCTD submission requirement.

Register your entire team to listen and discover:

  • How an IND maps to the eCTD table of contents
  • The benefits gained by sponsors who submit INDs electronically when transitioning to the process of submitting marketing applications (NDAs and BLAs)
  • The folder structure, document content format and navigation backbone standards
  • How to prepare compliant source documents and datasets for eCTD submissions
  • What the FDA's perspective is on INDs in eCTD format

Register now and you'll have all the steps you need to take when preparing and submitting an IND in eCTD format.

This presentation is a must for professionals in the drug, biotech and biologic industry companies including:

  • Compliance officers
  • Consultants/service providers
  • Data management and statistics personnel
  • Engineering and design control teams
  • Executive management
  • Managers
  • R&D staff
  • Dossier managers
  • IT personnel who support regulatory staff
  • Clinical affairs personnel


  • Medical writers
  • Regulatory/legislative affairs professionals
  • Documentation/report services staff
  • Clinical project specialists
  • Clinical research associates
  • Strategic planning and business development staff
  • Study research coordinators
  • Study sponsors
  • Training personnel


Antoinette Azevedo, founder of e-Submissions, advises all sizes of biotechnology and pharmaceutical companies on the use of technology to manage regulatory documents and publish electronic submissions. Her clients range from large, international pharmaceutical companies to small, virtual biotechnology companies.

Register now!

Date: April 6–24, 2009
Location: Your office or conference room (no need to travel!)
Time: Anytime

Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.

We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Registrations may not be cancelled. Please contact customer service to make any substitutions.

Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.